Price
No data yet.
Social Signal Score
Analyst Ratings
9 analystsRevenue
$5.31M+533.77%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Erez Raphael
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Employees
- 163
- Beta
- 1.18
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -6.10
Financials
Revenue
$5.31M+533.8%Net Income
$-8.85MEBITDA
$-7.25MFree Cash Flow
$-5.57MEPS (diluted)
$-0.73Shares Outstanding (diluted)
12.06M+3252.0%Operating Expenses
$11.19MCash & Debt
$31.15MReturn of Capital
$0.00Revenue by Segment (annual)
$14.93MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $22.36M | $-41.71M | $-0.81 |
| 2024 | $27.04M | $-42.75M | $-0.74 |
| 2023 | $20.35M | $-59.43M | $-1.93 |
| 2022 | $27.66M | $-62.19M | $-2.63 |
| 2021 | $20.51M | $-76.76M | $-4.63 |
| 2020 | $7.58M | $-29.45M | $-5.55 |
| 2019 | $7.56M | $-17.74M | $-7.84 |
| 2018 | $7.39M | $-17.80M | $-15.21 |
| 2017 | $5.17M | $-15.74M | $-32.70 |
| 2016 | $2.80M | $-10.89M | $-41.85 |
| 2015 | $823.0K | $-7.14M | $-75.27 |
| 2014 | $51.0K | $-12.88M | $-534.14 |
| 2013 | $0.00 | $-13.93M | $-1369.35 |
| 2012 | $0.00 | $-5.69M | $-512.72 |
Valuation
DRIOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+0.00%Social Signal Score
Mentions (10)
- Newsprnewswire.com·3d ago·Negative
…health outcomes and in-year healthcare cost savings Revenue contribution to Dario to begin in 2027 NEW YORK, Nov. 19, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced a strategic partnership with WebMD Health Services, one of the industry's leading well-being and population health organizations serving more than 3,500 employers, health plans, health systems and public secto…
View source ↗ - Newszacks.com·10d ago·Negative
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $1.85 per share a year ago.
View source ↗ - Newsprnewswire.com·18d ago·Negative
…he Board's view on the convergence of consumer and payer-led healthcare and chronic care management NEW YORK, Nov. 4, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that its Board of Directors (the "Board") has appointed John R. Palumbo as Chairman of the Board, effective November 3, 2026.
View source ↗ - Newsprnewswire.com·20d ago·Negative
…n Thursday, November 12, 2026 Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, Nov. 2, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leading artificial intelligence ("AI")-powered healthcare technology company transforming the management of chronic conditions, announced today that it will release its financial results for the 3rd quarter ended September 30th, 2026 and will host a conference call and webcast at 8:30 a.m.
View source ↗ - Newsprnewswire.com·27d ago·Neutral
…s, delivering greater value to payers while increasing the Company's annual recurring revenue base NEW YORK, Oct. 26, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that a leading regional grocery retailer client has expanded its contract with Dario to add Dario Women™, the Company's recently launched women's health solution suppo…
View source ↗ - Newsprnewswire.com·47d ago·Neutral
… payers including employers, health plans, health systems and accountable care organizations (ACOs) NEW YORK, Oct. 6, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced the results of a review titled "An Independent Review of Evidence Supporting DarioHealth's Clinical and Cost-Savings Impact" conducted by the Managed Care Services Tea…
View source ↗ - Newsprnewswire.com·66d ago·Negative
…lth plan signed through Amwell in the past 12 months, following contracts in Arizona and Florida NEW YORK, Sept. 17, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced a new contract with a leading health plan in New Jersey, one of the largest in the state representing approximately 1.5 million covered lives.
View source ↗ - Newsmarketbeat.com·103d ago·Neutral
DarioHealth Q2 Earnings Call Highlights DarioHealth NASDAQ: DRIO reported second-quarter 2026 revenue of $5.2 million, down from $5.6 million in the first quarter and $5.4 million a year earlier, as the company continued to shift away from pharmaceutical services revenue toward recurring B2B2C business.
View source ↗ - Newszacks.com·103d ago·Negative
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $2.4 per share a year ago.
View source ↗ - Newsprnewswire.com·103d ago·Neutral
DarioHealth Reports Second Quarter 2026 Financial Results Second quarter 2026 revenue was $5.2 million, reflecting the Company's strategic decision to discontinue certain pharmaceutical-related business Gross margin increased to 62%, compared to 57% in the first quarter of 2026 and 55% in the second quarter of 2025; non-GAAP B2B2C gross margin was approximately 80% for the 10th consecutive quarter Operating loss decreased by 30% year-over-year and 11% quarter-over-quarter Operating expenses decl
View source ↗
Earnings
Thu, Mar 18(in 4 months)
Consensus estimate $-0.71 per share
Typical surprise +25.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 12$-0.73 vs $-0.95beat
- Tue, Aug 11$-0.85 vs $-1.22beat
- Wed, May 13$-0.81 vs $-1.09beat
- Thu, Mar 19$-0.80 vs $-2.44beat
- Thu, Nov 13$-1.85 vs $-3.97beat
- Tue, Aug 12$-2.40 vs $-2.20miss
Estimates and results for DRIO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DRIO officers and directors.
- Bought
- $193k
- Sold
- $895k
24 trades
10 trades
- Matheis Dennisbought
- Nelson Steven Charlesbought
- Stern Adam Kbought
- Nelson Steven Charlesbought
- Nelson Steven Charlesbought
- Nelson Steven Charlesbought
- Nelson Steven Charlesbought
- Nelson Steven Charlesbought
66 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in DRIO.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
